BRIEF published on 09/03/2026 at 16:21, 1 month 28 days ago Sartorius Stedim Biotech Declares Share and Voting Rights Details Voting Rights Shares Regulatory Compliance Sartorius Stedim Biotech Issued Capital
PRESS RELEASE published on 09/03/2026 at 16:16, 1 month 28 days ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL Sartorius Stedim Biotech SA declares the number of shares and voting rights in the issued capital. Important regulatory announcement disclosed Voting Rights Capital Shares Sartorius Stedim Biotech Regulatory Announcement
BRIEF published on 08/04/2026 at 10:16, 2 months 29 days ago Sartorius Stedim Biotech Announces Share and Voting Rights Update Voting Rights Shares Regulatory Compliance Sartorius Stedim Biotech Issued Capital
BRIEF published on 08/04/2026 at 10:16, 2 months 29 days ago Sartorius Stedim Biotech: Declaration of Shares and Voting Rights Share Capital Voting Rights Actions Finance Sartorius Stedim
PRESS RELEASE published on 08/04/2026 at 10:12, 2 months 29 days ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL Sartorius Stedim Biotech SA in France discloses total shares and voting rights as of July 31, 2026, in accordance with legal requirements Voting Rights Shares Disclosure Sartorius Stedim Biotech France
PRESS RELEASE published on 08/04/2026 at 10:11, 2 months 29 days ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL Sartorius Stedim Biotech SA declares number of shares and voting rights in issued capital as of July 31, 2026. Regulatory announcement Voting Rights Shares Sartorius Stedim Biotech Regulatory Announcement Capital Declaration
PRESS RELEASE published on 07/23/2026 at 09:22, 3 months 10 days ago First-Half Financial Report January to June 2026
BRIEF published on 07/23/2026 at 07:05, 3 months 10 days ago Sartorius Stedim Biotech Shows Steady Growth Amid Tariff Adjustments EBITDA Margin Sales Revenue Product Launches Biotech Growth Tariff Impact
BRIEF published on 07/23/2026 at 07:05, 3 months 10 days ago Sartorius Stedim Biotech's half-year performance in 2026 EBITDA Revenue Sartorius Stedim Biotech Half-year Growth Customs Duties
PRESS RELEASE published on 07/23/2026 at 07:00, 3 months 10 days ago Sartorius Stedim Biotech continues positive development and expands profitable growth Sartorius Stedim Biotech reports robust growth in sales revenue, EBITDA, and net profit in H1 2026. The company confirms guidance for 2026 amid positive business development EBITDA Sartorius Stedim Biotech Sales Revenue Guidance H1 2026
Published on 11/02/2026 at 13:30, 16 minutes ago Electric Metals (USA) Limited Announces Results of Annual Meeting of Stockholders
Published on 11/02/2026 at 13:30, 16 minutes ago Predictiv AI Awarded Metrolinx Master Agreement for On-Demand Transit Software and Related Services
Published on 11/02/2026 at 13:00, 46 minutes ago International Battery Metals Announces Second Quarter Fiscal 2027 Financial Results Conference Call and Webcast
Published on 11/02/2026 at 13:00, 46 minutes ago Bocana Resources Corp. provides an Update on the Proposed Transaction with London Gold LLC
Published on 11/02/2026 at 13:00, 46 minutes ago Electrovaya Ranks Fourth Among Canada's Enterprise - Industry Leaders in Deloitte's Technology Fast 50(TM) Program
Published on 11/02/2026 at 13:20, 26 minutes ago Westpac 2026 Presentation and Investor Discussion Pack
Published on 11/02/2026 at 13:19, 27 minutes ago Westpac 2026 Full Year Results email to shareholders
Published on 10/30/2026 at 23:00, 2 days 14 hours ago BIOPHYTIS REPORTS FIRST- HALF 2026 RESULTS AND PROVIDES AN UPDATE ON ITS STRATEGY
Published on 10/30/2026 at 18:00, 2 days 19 hours ago 2026 half-year earnings & third quarter revenue
Published on 10/30/2026 at 12:00, 3 days 1 hour ago Capital increase through exercise of subscription rights
